15,000 women a year with breast cancer could benefit from whole genome sequencing, say researchers
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-Nov-2025 09:11 ET (7-Nov-2025 14:11 GMT/UTC)
Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over 15,000 women a year, say scientists at the University of Cambridge.
New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller than 5mm commonly found in the environment – can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer.